UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009155 |
|---|---|
| Receipt number | R000010735 |
| Scientific Title | Tamoxifen Response by CYP2D6 Genotype-Based Treatment in Patients with Metastatic or Recurrent Breast Cancer |
| Date of disclosure of the study information | 2012/10/20 |
| Last modified on | 2022/07/06 13:46:10 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/10/20 14:15:20 | ||
| 2 | Update | 2012/12/26 16:28:24 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2012/12/26 17:03:50 | Anticipated trial start date |
|
| 4 | Update | 2013/12/26 20:06:58 | TEL Address TEL Homepage URL |
|
| 5 | Update | 2014/09/02 13:16:51 | Region |
|
| 6 | Update | 2014/09/02 13:30:50 | Key secondary outcomes Key secondary outcomes |
|
| 7 | Update | 2014/09/02 14:16:01 | Key inclusion criteria Key exclusion criteria |
|
| 8 | Update | 2014/09/02 14:30:58 | Key secondary outcomes |
|
| 9 | Update | 2014/09/02 14:32:54 | Key inclusion criteria |
|
| 10 | Update | 2015/04/21 11:50:40 | Organization Organization |
|
| 11 | Update | 2015/09/28 18:52:01 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Homepage URL Institute Institute Organization Organization Category of Funding Organization Name of secondary funder(s) Name of secondary funder(s) |
|
| 12 | Update | 2016/05/17 12:36:08 | Randomization unit Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Interventions/Control_3 Target sample size |
|
| 13 | Update | 2016/05/17 12:40:32 | Organization Name of primary person or sponsor Organization Organization Category of Funding Organization |
|
| 14 | Update | 2016/08/03 10:08:38 | Recruitment status Last follow-up date |
|
| 15 | Update | 2017/04/24 09:02:33 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 16 | Update | 2018/05/07 11:14:03 | Recruitment status |
|
| 17 | Update | 2018/06/19 11:48:06 | Publication of results URL related to results and publications |
|
| 18 | Update | 2022/07/06 13:32:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Last name of contact person Last name of contact person Zip code Organization Organization Organization Address Address Tel |
|
| 19 | Update | 2022/07/06 13:44:44 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 20 | Update | 2022/07/06 13:46:10 | Date of IRB |
